N

NovaBay Pharmaceuticals

NBY

0.52250
USD
-0.0755
(-12.63%)
Market Closed
Volume
551
EPS
0
Div Yield
0
P/E
-0
Market Cap
2,687,131
Related Instruments
A
AQST
-0.23000
(-6.01%)
3.60000 USD
C
CRIS
-0.60000
(-11.05%)
4.83000 USD
MRNA
-25.020
(-20.99%)
94.160 USD
O
OGEN
-0.03000
(-2.88%)
1.01000 USD
T
TTNP
-0.42000
(-7.00%)
5.58000 USD
V
VXRT
-0.01170
(-1.74%)
0.65890 USD
News

Title: NovaBay Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratorytested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.